Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 53

1.

Who benefit from school doctors' health checks: a prospective study of a screening method.

Nikander K, Kosola S, Kaila M, Hermanson E.

BMC Health Serv Res. 2018 Jun 27;18(1):501. doi: 10.1186/s12913-018-3295-3.

2.

Drug Delivery in Asthmatic Children Following Coordinated and Uncoordinated Inhalation Maneuvers: A Randomized Crossover Trial.

Berlinski A, von Hollen D, Hatley RHM, Hardaker LEA, Nikander K.

J Aerosol Med Pulm Drug Deliv. 2017 Jun;30(3):182-189. doi: 10.1089/jamp.2016.1337. Epub 2016 Dec 15.

PMID:
27977309
3.

The size and behavior of the human upper airway during inhalation of aerosols.

Nikander K, von Hollen D, Larhrib H.

Expert Opin Drug Deliv. 2017 May;14(5):621-630. doi: 10.1080/17425247.2016.1227780. Epub 2016 Sep 2. Review.

PMID:
27547842
4.

Factors to consider when selecting a nebulizer for a new inhaled drug product development program.

Elphick M, von Hollen D, Pritchard JN, Nikander K, Hardaker LE, Hatley RH.

Expert Opin Drug Deliv. 2015 Aug;12(8):1375-87. doi: 10.1517/17425247.2015.1014339. Epub 2015 Mar 10. Review.

PMID:
25758911
5.

Lung deposition of 99mTc-radiolabeled albuterol delivered through a pressurized metered dose inhaler and spacer with facemask or mouthpiece in children with asthma.

Ditcham W, Murdzoska J, Zhang G, Roller C, von Hollen D, Nikander K, Devadason SG.

J Aerosol Med Pulm Drug Deliv. 2014 Aug;27 Suppl 1:S63-75. doi: 10.1089/jamp.2014.1139.

PMID:
25054483
6.

An instrumented valved holding chamber with facemask to measure application forces and flow in young asthmatic children.

Minh KT, von Hollen D, von Königslöw AJ, Nikander K, Janssens HM.

J Aerosol Med Pulm Drug Deliv. 2014 Aug;27 Suppl 1:S55-62. doi: 10.1089/jamp.2014.1129.

PMID:
25054482
7.

The evolution of spacers and valved holding chambers.

Nikander K, Nicholls C, Denyer J, Pritchard J.

J Aerosol Med Pulm Drug Deliv. 2014 Aug;27 Suppl 1:S4-23. doi: 10.1089/jamp.2013.1076. Review.

PMID:
25054481
8.

Methodology for the in vitro evaluation of the delivery efficiency from valved holding chambers with facemasks.

Xu Z, Hsu W, von Hollen D, Viswanath A, Nikander K, Dalby R.

J Aerosol Med Pulm Drug Deliv. 2014 Aug;27 Suppl 1:S44-54. doi: 10.1089/jamp.2013.1074. Epub 2013 Nov 12.

PMID:
24219816
9.

Continuous versus intermittent inhaled corticosteroid (budesonide) for mild persistent asthma in children--not too much, not too little.

Turpeinen M, Pelkonen AS, Selroos O, Nikander K, Haahtela T.

Thorax. 2012 Feb;67(2):100-2. doi: 10.1136/thoraxjnl-2011-200246. Epub 2011 Oct 28. No abstract available.

PMID:
22038795
10.

True adherence with the Turbuhaler in young children with asthma.

Nikander K, Turpeinen M, Pelkonen AS, Bengtsson T, Selroos O, Haahtela T.

Arch Dis Child. 2011 Feb;96(2):168-73. doi: 10.1136/adc.2010.187724. Epub 2010 Nov 19.

PMID:
21097795
11.

Challenges and opportunities in respiratory drug delivery devices.

Nikander K.

Expert Opin Drug Deliv. 2010 Nov;7(11):1235-8. doi: 10.1517/17425247.2010.525231. Epub 2010 Oct 12.

PMID:
20939686
12.

Unaffected peak inspiratory flow through Turbuhaler during histamine inhalation challenge.

Nikander K, Turpeinen M, Pelkonen AS, Selroos O, Haahtela T.

Allergy. 2011 Feb;66(2):302-3. doi: 10.1111/j.1398-9995.2010.02471.x. Epub 2010 Aug 30. No abstract available.

PMID:
20804463
13.

Bone mineral density in children treated with daily or periodical inhaled budesonide: the Helsinki Early Intervention Childhood Asthma study.

Turpeinen M, Pelkonen AS, Nikander K, Sorva R, Selroos O, Juntunen-Backman K, Haahtela T.

Pediatr Res. 2010 Aug;68(2):169-73. doi: 10.1203/00006450-201011001-00329.

PMID:
20485203
14.

Evaluation of patient-reported outcomes and quality of life with the I-neb AAD system in patients with chronic obstructive pulmonary disease.

Goodman N, Morgan M, Nikander K, Hinch S, Coughlin S.

J Aerosol Med Pulm Drug Deliv. 2010 Apr;23 Suppl 1:S61-70. doi: 10.1089/jamp.2009.0767.

15.

Domiciliary experience of the Target Inhalation Mode (TIM) breathing maneuver in patients with cystic fibrosis.

Denyer J, Black A, Nikander K, Dyche T, Prince I.

J Aerosol Med Pulm Drug Deliv. 2010 Apr;23 Suppl 1:S45-54. doi: 10.1089/jamp.2009.0777.

16.

Mode of breathing-tidal or slow and deep-through the I-neb Adaptive Aerosol Delivery (AAD) system affects lung deposition of (99m)Tc-DTPA.

Nikander K, Prince I, Coughlin S, Warren S, Taylor G.

J Aerosol Med Pulm Drug Deliv. 2010 Apr;23 Suppl 1:S37-43. doi: 10.1089/jamp.2009.0786.

17.

The Adaptive Aerosol Delivery system in a telehealth setting: patient acceptance, performance and feasibility.

Nikander K, Denyer J, Dodd M, Dyche T, Webb K, Weller P, Stableforth D.

J Aerosol Med Pulm Drug Deliv. 2010 Apr;23 Suppl 1:S21-7. doi: 10.1089/jamp.2009.0770.

18.

Thirteen-year follow-up of early intervention with an inhaled corticosteroid in patients with asthma.

Haahtela T, Tamminen K, Kava T, Malmberg LP, Rytilä P, Nikander K, Persson T, Selroos O.

J Allergy Clin Immunol. 2009 Dec;124(6):1180-5. doi: 10.1016/j.jaci.2009.09.036.

PMID:
20004779
19.

Skin thickness in children treated with daily or periodical inhaled budesonide for mild persistent asthma. The Helsinki early intervention childhood asthma study.

Turpeinen M, Raitio H, Pelkonen AS, Nikander K, Sorva R, Selroos O, Juntunen-Backman K, Haahtela T.

Pediatr Res. 2010 Feb;67(2):221-5. doi: 10.1203/PDR.0b013e3181c6e574.

PMID:
19858777
20.

Ophthalmologic findings in children with asthma receiving inhaled budesonide.

Pelkonen A, Kari O, Selroos O, Nikander K, Haahtela T, Turpeinen M.

J Allergy Clin Immunol. 2008 Oct;122(4):832-834. doi: 10.1016/j.jaci.2008.07.013. Epub 2008 Aug 28. No abstract available.

PMID:
18760462
21.

Daily versus as-needed inhaled corticosteroid for mild persistent asthma (The Helsinki early intervention childhood asthma study).

Turpeinen M, Nikander K, Pelkonen AS, Syvänen P, Sorva R, Raitio H, Malmberg P, Juntunen-Backman K, Haahtela T.

Arch Dis Child. 2008 Aug;93(8):654-9. Epub 2007 Jul 18.

22.

Jet nebulizers versus pressurized metered dose inhalers with valved holding chambers: effects of the facemask on aerosol delivery.

Nikander K, Berg E, Smaldone GC.

J Aerosol Med. 2007;20 Suppl 1:S46-55; discussion S55-8.

PMID:
17411405
24.

Adaptive Aerosol Delivery (AAD) technology.

Denyer J, Nikander K, Smith NJ.

Expert Opin Drug Deliv. 2004 Nov;1(1):165-76. Erratum in: Expert Opin Drug Deliv. 2005 Jan;2(1):199.

PMID:
16296727
25.

Variation in pediatric aerosol delivery: importance of facemask.

Smaldone GC, Berg E, Nikander K.

J Aerosol Med. 2005 Fall;18(3):354-63.

PMID:
16181009
26.

Induced sputum in children with newly diagnosed mild asthma: the effect of 6 months of treatment with budesonide or disodium cromoglycate.

Rytilä P, Pelkonen AS, Metso T, Nikander K, Haahtela T, Turpeinen M.

Allergy. 2004 Aug;59(8):839-44.

PMID:
15230816
27.

Parents' adherence with nebulizer treatment of their children when using an adaptive aerosol delivery (AAD) system.

Nikander K, Arheden L, Denyer J, Cobos N.

J Aerosol Med. 2003 Fall;16(3):273-81.

PMID:
14572325
28.

Systemic availability and lung deposition of budesonide via three different nebulizers in adults.

Dahlström K, Thorsson L, Larsson P, Nikander K.

Ann Allergy Asthma Immunol. 2003 Feb;90(2):226-32.

PMID:
12602671
29.

Acceptability, reproducibility, and sensitivity of forced expiratory volumes and peak expiratory flow during bronchial challenge testing in asthmatic children.

Malmberg LP, Nikander K, Pelkonen AS, Syvänen P, Koljonen T, Haahtela T, Turpeinen M.

Chest. 2001 Dec;120(6):1843-9.

PMID:
11742911
30.

Breathing patterns and aerosol delivery: impact of regular human patterns, and sine and square waveforms on rate of delivery.

Nikander K, Denyer J, Smith N, Wollmer P.

J Aerosol Med. 2001 Fall;14(3):327-33.

PMID:
11693844
31.

Nebulized budesonide after hospitalization for recurrent bronchial obstruction in children younger than 18 months.

Lødrup Carlsen KC, Carlsen KH, Nikander K, Leegaard J, Havnen J, Steen-Johnsen J, Winsness A.

Pediatr Allergy Immunol. 2001 Jun;12(3):159-65.

PMID:
11473681
32.
33.

Validation of a new breathing simulator generating and measuring inhaled aerosol with adult breathing patterns.

Nikander K, Denyer J, Everard M, Smaldone GC.

J Aerosol Med. 2000 Summer;13(2):139-46.

PMID:
11010594
35.
36.

Metered dose inhaler add-on devices: is the inhaled mass of drug dependent on the size of the infant?

Turpeinen M, Nikander K, Malmberg LP, Pelkonen A.

J Aerosol Med. 1999 Fall;12(3):171-6.

PMID:
10623333
37.
38.

Reproducibility of home spirometry in children with newly diagnosed asthma.

Pelkonen AS, Nikander K, Turpeinen M.

Pediatr Pulmonol. 2000 Jan;29(1):34-8.

PMID:
10613784
39.

Effects of equipment dead space and pediatric breathing patterns on inhaled mass of nebulized budesonide.

Nikander K, Denyer J, Smaldone GC.

J Aerosol Med. 1999 Summer;12(2):67-73.

PMID:
10539709
40.

The conventional ultrasonic nebulizer proved inefficient in nebulizing a suspension.

Nikander K, Turpeinen M, Wollmer P.

J Aerosol Med. 1999 Summer;12(2):47-53.

PMID:
10539706
41.
42.
43.

Effect of 1 year daily treatment with 400 microg budesonide (Pulmicort Turbuhaler) in newly diagnosed asthmatics.

Osterman K, Carlholm M, Ekelund J, Kiviloog J, Nikander K, Nilholm L, Salomonsson P, Strand V, Venge P, Zetterström O.

Eur Respir J. 1997 Oct;10(10):2210-5.

44.
45.

Effects of reducing or discontinuing inhaled budesonide in patients with mild asthma.

Haahtela T, Järvinen M, Kava T, Kiviranta K, Koskinen S, Lehtonen K, Nikander K, Persson T, Selroos O, Sovijärvi A, et al.

N Engl J Med. 1994 Sep 15;331(11):700-5.

46.

Use of budesonide Turbuhaler in young children suspected of asthma.

Bisgaard H, Pedersen S, Nikander K.

Eur Respir J. 1994 Apr;7(4):740-2.

47.

Drug delivery systems.

Nikander K.

J Aerosol Med. 1994;7(Suppl 1):S19-24.

PMID:
10147077
48.

Treatment of severe steroid dependent preschool asthma with nebulised budesonide suspension.

Ilangovan P, Pedersen S, Godfrey S, Nikander K, Noviski N, Warner JO.

Arch Dis Child. 1993 Mar;68(3):356-9.

49.

How much nebulised budesonide reaches infants and toddlers?

Lødrup Carlsen KC, Nikander K, Carlsen KH.

Arch Dis Child. 1992 Sep;67(9):1077-9.

50.

Delivery of micronized budesonide suspension by metered dose inhaler and jet nebulizer into a neonatal ventilator circuit.

Arnon S, Grigg J, Nikander K, Silverman M.

Pediatr Pulmonol. 1992 Jul;13(3):172-5.

PMID:
1437332

Supplemental Content

Loading ...
Support Center